Joel Reid

16PUBLICATIONS
94CO-AUTHORS
Molecular targetsBiologically active moleculesSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

|Oct 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.

Katherine A Janeway, Alexander J Chou, Allen Buxton

|Apr 14, 2025
Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease.

Luke C Doskey, Cole R Scholtz, Nora R Vail

|Feb 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial.

Adam L Green, Charles G Minard, Xiaowei Liu

|Dec 09, 2024
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children's Oncology Group ADVL1823).

Theodore W Laetsch, Stephan Voss, Kathleen Ludwig

|Sep 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

Margaret E Macy, Rajen Mody, Joel M Reid

Pageof 3

Frequent Collaborators

7 joint publications

Brenda J Weigel

7 joint publications

Elizabeth Fox

6 joint publications

Katherine A Janeway

4 joint publications

Margaret M Mooney